3A.B. Lawrence de koning,Geoff H. Werstuck,Ji Zhou,et al. Hyperhomocysteinemia and its role in the development of atherosclerosis [J].C1inical Biochemistry,2003,36(6):431～441.
3Boushey CJ, Beresford SAA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA, 1995, 274:1049-1057.
4Amesen E, Refsum H, Bonaa KH, et al. Serum total homocysteine and coronary heart disease. Int J Epidemiol, 1995, 24 : 704-709,.
5Bostom AG, Silbershatz H, Rosenberg IH, et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med, 1999, 159:1077-1080.
6Evans RW, ShatenBJ, Hempel JD, et al. Homocysteine and risk of cardiovascular disease in the multiple risk factor intervention trial. Artenoscler Thromb Vasc Biol, 1997, 17:1947-1953.
7Heil SG, Lievers KJ, Boers GH, et al. Betaine-homocysteine methyltransferase(BHMT) t genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans. Mol Genet Metab, 2000, 71:511-519.
8PACIFIC study group. Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heaxt disease. Eur Heart J, 2002, 23: 1509-1515.
9Brattstrom L, Landgren F, Israelsson B, et al. Lowering blood homocysteine with folic acid based supplements: meta-analysls of randomlsed trials. Homocystelne lowering triallsts collaboration. BMJ, 1998, 316:894-898.
10Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA, 1993, 270:2693-2698.
